May 13, 2020 / 1:09 PM / 25 days ago

BRIEF-Philips Gets FDA Clearance For Use Of Ultrasound Portfolio To Manage COVID-19-Related Complications

May 13 (Reuters) - Koninklijke Philips NV:

* PHILIPS RECEIVES FDA CLEARANCE FOR THE USE OF ITS ULTRASOUND PORTFOLIO TO MANAGE COVID-19-RELATED LUNG AND CARDIAC COMPLICATIONS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below